Nontuberculous Mycobacterial Infection
Showing 26 - 50 of >10,000
Drug Exposure and Minimum Inhibitory Concentration in Treatment
Not yet recruiting
- Mycobacterium Avium Complex
- +3 more
- Drug exposure
-
Shanghai, ChinaShanghai Pulmonary Hospital
Apr 10, 2023
Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection Trial (Delpazolid)
Not yet recruiting
- Nontuberculous Mycobacterium Infection
- Mycobacterium Abscessus Infection
- (no location specified)
Aug 21, 2023
Non-Tuberculous Mycobacterial Pneumonia Trial in Vancouver (Nitric Oxide gas at 160ppm)
Completed
- Non-Tuberculous Mycobacterial Pneumonia
- Nitric Oxide gas at 160ppm
-
Vancouver, British Columbia, CanadaGordon Leslie Diamond Health Care Centre
Jul 27, 2020
Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin
Recruiting
- Healthy
- Latent Tuberculosis Infection (LTBI)
- Tuberculin Purified Protein Derivative
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 22, 2022
Study of Nontuberculous Mycobacterial Lung Disease
Recruiting
- Nontuberculous Mycobacterial Lung Disease
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 23, 2020
Tuberculosis, Latent Tuberculosis, Nontuberculous Mycobacterium Infection Trial in Busan (therapeutic drug monitoring(TDM))
Recruiting
- Tuberculosis
- +2 more
- therapeutic drug monitoring(TDM)
-
Busan, Korea, Republic ofInje University Busan Paik Hoapital Clinical Trial Center
Mar 6, 2022
Nontuberculous Mycobacterium Infection Trial in United States (Gallium nitrate)
Recruiting
- Nontuberculous Mycobacterium Infection
- Gallium nitrate
-
Birmingham, Alabama
- +8 more
Jan 10, 2023
Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,
Recruiting
- Mycobacterium Avium Complex
- Nontuberculous Mycobacterium Infection
- Azithromycin
- +2 more
-
Loma Linda, California
- +26 more
Jan 18, 2023
NTM Lung Infection Due to MAC Trial (LAI 590 mg, Multi-drug regimen)
Completed
- NTM Lung Infection Due to MAC
- LAI 590 mg
- Multi-drug regimen
- (no location specified)
Jan 21, 2020
Non-tuberculous Mycobacterial Infections Trial in Bangkoknoi (Oral Tablet)
Unknown status
- Non-tuberculous Mycobacterial Infections
- Oral Tablet
-
Bangkoknoi, Bangkok, ThailandSiriraj Hospital
Apr 17, 2020
MAC Lung Disease Trial in United States (Epetraborole, Placebo)
Recruiting
- MAC Lung Disease
- Treatment Refractory MAC Lung Disease
- Epetraborole
- Placebo
-
Birmingham, Alabama
- +40 more
Jan 31, 2023
Performance Evaluation of the VIDAS TB-IGRA Assay.
Completed
- Active Tuberculosis
- +2 more
- Blood draw and IGRA test
-
Palo Alto, California
- +23 more
Jul 14, 2021
Mycobacterium Avium Complex Pulmonary Disease Trial in Seoul
Not yet recruiting
- Mycobacterium Avium Complex Pulmonary Disease
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 7, 2023
Multiplex PCR -Microarray-based Assay in Detection of
Completed
- Tuberculosis
- Non-Tuberculous Mycobacterial Pneumonia
- VereMTB
-
Sha Tin, Hong KongPrince of Wales Hospital
Aug 7, 2022
Bronchiectasis Comorbid Nontuberculous Mycobacteria
Unknown status
- Bronchiectasis
- Non-tuberculous Mycobacterial
-
Beijing, ChinaChina-Japan Friendship Hospital
Dec 31, 2019
Patients With Nontuberculous Mycobacterial Lung Disease
Completed
- Mycobacterium Infections, Nontuberculous
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 12, 2019
A Registry for Nontuberculous Mycobacterial Pulmonary Disease
Enrolling by invitation
- Nontuberculous Mycobacterial Pulmonary Disease
-
Seoul, Korea, Republic ofDepartment of Internal Medicine, Yonsei University College of Me
Nov 15, 2019
Mycobacterium Avium Complex Trial in Baltimore (Azithromycin)
Recruiting
- Mycobacterium Avium Complex
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Mar 7, 2022
Natural History Study of GATA2 Deficiency and Related Disorders
Recruiting
- GATA2 Deficiency
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
An Observational Study on Patients With NTM Pulmonary Disease
Not yet recruiting
- Clinical Outcomes
- NTM drug treatment
- (no location specified)
Jul 12, 2020
Non-Tuberculous Mycobacterial (NTM) Infections Trial in Canada, United States (Lamprene®/Clofazimine)
Available
- Non-Tuberculous Mycobacterial (NTM) Infections
- (no location specified)
Dec 14, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Bacterial Infections Trial in Worldwide (Individualised treatment
Recruiting
- Tuberculosis, Pulmonary
- +3 more
- Individualised treatment duration based on RNA transcriptomic model
-
Borstel, Schleswig-Holstein, Germany
- +4 more
Apr 7, 2021
Management of Patients With Known Respiratory Disease
Recruiting
- Cough
- +6 more
- Hyfe Cough Tracker
- Hyfe Air
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Nov 4, 2021
Factors Related to Non-tuberculous Mycobacterial Pulmonary
Unknown status
- Non-Tuberculous Mycobacterial Pneumonia
-
Hong Kong, Please Select, Hong KongChinese University of Hong
Dec 8, 2020